Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 102


Perspectives of online surveys in dermatology.

Arafa AE, Anzengruber F, Mostafa AM, Navarini AA.

J Eur Acad Dermatol Venereol. 2018 Oct 13. doi: 10.1111/jdv.15283. [Epub ahead of print] Review.


Clinical and genetic differences between pustular psoriasis subtypes.

Twelves S, Mostafa A, Dand N, Burri E, Farkas K, Wilson R, Cooper HL, Irvine AD, Oon HH, Kingo K, Köks S, Mrowietz U, Puig L, Reynolds N, Tan ES, Tanew A, Torz K, Trattner H, Valentine M, Wahie S, Warren RB, Wright A, Bata-Csörgő Z, Szell M, Griffiths CEM, Burden AD, Choon SE, Smith CH, Barker JN, Navarini AA, Capon F.

J Allergy Clin Immunol. 2018 Jul 21. pii: S0091-6749(18)31039-X. doi: 10.1016/j.jaci.2018.06.038. [Epub ahead of print]


Praxis der Teledermatologie.

Augustin M, Wimmer J, Biedermann T, Blaga R, Dierks C, Djamei V, Elmer A, Elsner P, Enk A, Gass S, Henningsen M, Hofman-Wellenhof R, von Kiedrowski R, Kunz HD, Liebram C, Navarini A, Otten M, Reusch M, Schüller C, Zink A, Strömer K.

J Dtsch Dermatol Ges. 2018 Jul;16 Suppl 5:6-57. doi: 10.1111/ddg.13512.


Generalized pustular psoriasis - a model disease for specific targeted immunotherapy, systematic review.

Boehner A, Navarini AA, Eyerich K.

Exp Dermatol. 2018 Oct;27(10):1067-1077. doi: 10.1111/exd.13699. Epub 2018 Jul 20. Review.


Limited clinical utility of HLA-Cw6 genotyping for outcome prediction in psoriasis patients under ustekinumab therapy: a monocentric, retrospective analysis.

Anzengruber F, Ghosh A, Maul JT, Drach M, Navarini AA.

Psoriasis (Auckl). 2018 Mar 23;8:7-11. doi: 10.2147/PTT.S161437. eCollection 2017.


Survival of Second-Line Biologics in Psoriasis: The British BADBIR Registry Data Informs Daily Practice.

Navarini AA, French LE.

J Invest Dermatol. 2018 Apr;138(4):726-728. doi: 10.1016/j.jid.2018.02.008.


Unmet digital health service needs in dermatology patients.

Greis C, Meier Zürcher C, Djamei V, Moser A, Lautenschlager S, Navarini AA.

J Dermatolog Treat. 2018 Nov;29(7):643-647. doi: 10.1080/09546634.2018.1441488. Epub 2018 Mar 14.


TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis.

Conrad C, Di Domizio J, Mylonas A, Belkhodja C, Demaria O, Navarini AA, Lapointe AK, French LE, Vernez M, Gilliet M.

Nat Commun. 2018 Jan 2;9(1):25. doi: 10.1038/s41467-017-02466-4.


Expression Patterns of TNFα, MAdCAM1, and STAT3 in Intestinal and Skin Manifestations of Inflammatory Bowel Disease.

Vavricka SR, Galván JA, Dawson H, Soltermann A, Biedermann L, Scharl M, Schoepfer AM, Rogler G, Prinz Vavricka MB, Terracciano L, Navarini A, Zlobec I, Lugli A, Greuter T.

J Crohns Colitis. 2018 Feb 28;12(3):347-354. doi: 10.1093/ecco-jcc/jjx158.


Clinical Disease Patterns in a Regional Swiss Cohort of 34 Pyoderma Gangrenosum Patients.

Kolios AGA, Gübeli A, Meier B, Maul JT, Kündig T, Nilsson J, Hafner J, Guenova E, Kerl K, Anliker M, Kempf W, Navarini AA, French LE, Cozzio A.

Dermatology. 2017;233(4):268-276. doi: 10.1159/000481432. Epub 2017 Nov 7.


TNFα and IL-17A are differentially expressed in psoriasis-like vs eczema-like drug reactions to TNFα antagonists.

Deubelbeiss C, Kolios AGA, Anzengruber F, French LE, Yawalkar N, Kempf W, Kerl K, Meier B, Navarini AA.

J Cutan Pathol. 2018 Jan;45(1):23-28. doi: 10.1111/cup.13055. Epub 2017 Nov 22.


Detection of Sp110 by Flow Cytometry and Application to Screening Patients for Veno-occlusive Disease with Immunodeficiency.

Marquardsen FA, Baldin F, Wunderer F, Al-Herz W, Mikhael R, Lefranc G, Baz Z, Rezaee F, Hanna R, Kfir-Erenfeld S, Stepensky P, Meyer B, Jauch A, Bigler MB, Burgener AV, Higgins R, Navarini AA, Church JA, Chou J, Geha R, Notarangelo LD, Hess C, Berger CT, Bloch DB, Recher M.

J Clin Immunol. 2017 Oct;37(7):707-714. doi: 10.1007/s10875-017-0431-5. Epub 2017 Aug 21.


Wide range of age of onset and low referral rates to psychiatry in a large cohort of acne excoriée at a Swiss tertiary hospital.

Anzengruber F, Ruhwinkel K, Ghosh A, Klaghofer R, Lang UE, Navarini AA.

J Dermatolog Treat. 2018 May;29(3):277-280. doi: 10.1080/09546634.2017.1364693. Epub 2017 Aug 24.


A case of tinea incognita and differential diagnosis of figurate erythema.

Maul JT, Maier PW, Anzengruber F, Murer C, Bosshard PP, Kerl K, French LE, Navarini AA.

Med Mycol Case Rep. 2017 Jul 3;18:8-11. doi: 10.1016/j.mmcr.2017.07.001. eCollection 2017 Dec.


Swiss Practice Recommendations for the Management of Hidradenitis Suppurativa/Acne Inversa.

Hunger RE, Laffitte E, Läuchli S, Mainetti C, Mühlstädt M, Schiller P, Lapointe AK, Meschberger P, Navarini AA.

Dermatology. 2017;233(2-3):113-119. doi: 10.1159/000477459. Epub 2017 Jul 7. Review.


Skin Manifestations of Inflammatory Bowel Disease.

Greuter T, Navarini A, Vavricka SR.

Clin Rev Allergy Immunol. 2017 Dec;53(3):413-427. doi: 10.1007/s12016-017-8617-4. Review.


Interruption of Sneddon-Wilkinson Subcorneal Pustulation with Infliximab.

Kretschmer L, Maul JT, Hofer T, Navarini AA.

Case Rep Dermatol. 2017 Apr 27;9(1):140-144. doi: 10.1159/000468917. eCollection 2017 Jan-Apr. Review.


Rapid Involution of Pustules during Topical Steroid Treatment of Acute Generalized Exanthematous Pustulosis.

Kley C, Murer C, Maul JT, Meier B, Anzengruber F, Navarini AA.

Case Rep Dermatol. 2017 Apr 27;9(1):135-139. doi: 10.1159/000471842. eCollection 2017 Jan-Apr.


Extreme Phenotype of Epidermal Growth Factor Receptor Inhibitor-induced Destructive Folliculitis.

Anzengruber F, Meier B, Maul JT, Kerl K, French LE, Navarini AA.

Int J Trichology. 2016 Oct-Dec;8(4):176-179. doi: 10.4103/0974-7753.203174.


Generalized Comedones, Acne, and Hidradenitis Suppurativa in a Patient with an FGFR2 Missense Mutation.

Higgins R, Pink A, Hunger R, Yawalkar N, Navarini AA.

Front Med (Lausanne). 2017 Feb 28;4:16. doi: 10.3389/fmed.2017.00016. eCollection 2017.

Supplemental Content

Loading ...
Support Center